Asher Biotherapeutics logo

Asher Biotherapeutics

A biotechnology company offering precision immunotherapy cancer treatments.

2

Funding Rounds

$163.0m

Money raised

Overview

A biotechnology company offering precision immunotherapy cancer treatments.

Funding series

Funding Series Analysis

The company Asher Biotherapeutics has raised a total of $108m in funding over 2 rounds.

Key Insights:

  • Asher Bio Series B round, September 2021: $108m
  • Asher Biotherapeutics Series A round, March 23, 2021: $55m
Asher Biotherapeutics logo
Asher Bio Series B round, September 2021 $108m
Asher Biotherapeutics logo
Asher Biotherapeutics Series A round, March 23, 2021 $55m

Industries

Asher Biotherapeutics is active in the following industries: